Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
It is not approved by the US Food and Drug Administration (FDA), which means it hasn't passed the strict safety and efficacy trials required for all legal medical treatments
GHK-Cu treatment reduced reactive oxygen species (ROS) production, increased superoxide dismutase (SOD) activity, and decreased TNF- and IL-6 production by inhibiting NF-B p65 and p38 MAPK signaling in LPS-induced macrophages and ALI models
Skeletal muscle, ligament, and bone-defect models have produced comparable healing-rate findings, summarized in the 2021 wound-healing review (PMID 34267654) and the 2025 musculoskeletal narrative review (PMID 40789979)
Skin health and anti-aging Most popular use : Cosmetic and anti-aging applications
US$ 21.20
US$ 25.20
US$ 21.37
